Cardiac Implants Market Size, Share & Segmentation By Type(Pacemakers’ device, Cardiac Resynchronization Therapy Devices, Implantable hemodynamic Monitoring devices, Implanted heart rhythm monitors, Coronary stents, Implantable cardioverter Defibrillator, Heart Valve ), By Indications (Arrhythmias, Myocardial ischemia, Acute myocardial infarction, Heart failure), By Procedure (Angioplasty Open heart surgery), By Material (Metals and alloys Polymers Biological Materials), By End User (Hospitals, Specialty, Clinics, Others ), by region and Global Forecast 2023-2030
Report Id: SNS/HC/2667 | January 2023 | Region: Global | 126 Pages
Market Scope & Overview
Cardiac Implant Market size was valued at USD 24 Bn in 2022 and is expected to reach USD 38.25 Bn in 2030, and grow at a CAGR of 6% over the forecast period of 2023-2030.
According to our expert studies, there is a growing prevalence of heart diseases all around the globe, and also the rise in the aging population is the major driving factor for the cardiac implant market.
.jpg)
Cardiac implants are done for patients who are suffering from cardiovascular disease which includes heart failure and detached heartbeat fluctuations. We can say that cardiac implants are implanted in the heart to gain more information about the heart and its functioning. The changing lifestyle of people all around the globe and the daily habits which leads to cardiovascular issues are the obvious reason which is increasing the demand for cardiac implants. In the treatment of diseases like arrhythmias, myocardial infarction acute myocardial ischemia cardiac implant monitors are been used.
Market Dynamics
Drivers
-
Increase in cardiac diseases all around the globe
-
The demand for Cardiac implants
-
A rise in the aging population
Restrains
-
The overall price of cardiac implants
-
Stringent approval process
Opportunity
-
Technological upliftment in the cardiac implant field
Challenges
-
Side effects due to cardiac Implants
Impact of Covid 19
Covid 19 outbreak was a shock for every industry so did the health industry. Covid 19 impacted almost every aspect of medical devices, During the initial stage of covid 19 the number of patients for cardiac implants was reduced there were many reasons the obvious one was the quarantine system, no easy access to the hospitals, fear of coronavirus the other important factor. These reasons made it very hard for the patients to show up to the hospital for their treatment. But later on, due to the rise in heart patients due to the prone of covid 19 the demand for the cardiac implant again raised. Many technological advancements were planned for the cardiac implant procedure but due to covid, it got postponed.
Impacts of Russia Ukraine war
The Russia-Ukraine war has led to economic sanctions on multiple countries and has disrupted the global economic recovery from the covid19 pandemic at least in the short term. Another factor that caused problems was the supply chain disruption which affected the markets all around the globe.
Impact of the current ongoing recession
Technological advancement, and providing good service to the patients purchasing various ongoing hospital trends are the factors that get affected by economic conditions. Due to the economic conditions, there is said to be there will be minimal effect in the cardiovascular devices sector.
According to the reports given by US hospitals, there have been changes in the number of patients for regular check-ups compared to emergency cases because due to the economic crisis, people are neglecting minor health problems due to medical expenses which are leading to severe problems which they have to face.
Market Segmentation
By Device Type
-
Pacemaker’s device
-
Cardiac Resynchronization Therapy Devices
-
Implantable hemodynamic Monitoring devices
-
Implanted heart rhythm monitors
-
Coronary stents
-
Implantable cardioverter Defibrillator
-
Heart Valve
-
Others
By Indication
-
Arrhythmias
-
Myocardial ischemia
-
Acute myocardial infarction
-
Heart failure
By Procedure
-
Angioplasty
-
Open heart surgery
By Material
-
Metals and alloys
-
Polymers
-
Biological Materials
By End Users
-
Hospitals
-
Specialty Clinics
-
Others
Regional analysis
There were many obstacles faced by the cardiac implant plant due to the covid and Russia-Ukraine war. According to the data North America is likely to hold the largest market share for its growing aging population, increase in cardiac diseases, and adoption of electronic devices
Whereas in Europe there were many changes lately which include healthcare funds secured by the government which gave them a chance for technological betterment in the cardiac implant field also many insurance companies took initiatives for heart patients all around Europe. In Europe, Italy shared a market share of 9%.
According to our reports, there is an increase in the hill population due to lifestyle changes and this is the reason why APAC is said to be the fastest-growing market for Cardiac Implants.
REGIONAL COVERAGE:
-
North America
-
USA
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
The Netherlands
-
Rest of Europe
-
-
Asia-Pacific
-
Japan
-
south Korea
-
China
- India
- Australia
- Rest of Asia-Pacific
-
- The Middle East & Africa
- Israel
- UAE
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Key Players
BIOTRONIC SE& CO.kg, Abbott Laboratories, AMG International Braun Melsungen Ag, Johnson & Johnson Services, Inc, W L Gore & Associates, Inc Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation
Frequently Asked Questions (FAQ) :
What will be the forecasted market size value by the year 2030?
The market size value for the year 2030 year is USD 38.25Bn
What are the challenges this market may face in the coming years?
Side effects due to Cardiac Implants
Who are the end users of these markets?
Hospitals, Speciality Clinics, and Others
What is the driving factor for this market?
Increase in cardiac disease all around the globe.
This market is divided in how many segments ?
This market is divided into mainly five segments
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of the Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Cardiac Implant Market Segmentation, by device type
8.1 Pacemakers Device
8.2 Cardiac Resynchronization Therapy Devices
8.3 Implantable hemodynamic Monitoring devices
8.4 Implanted heart rhythm monitors
8.5 Coronary stents
8.6 Implantable Cardioverter Defibrillator
9. Cardiac Implant Market Segmentation, by Indications
9.1 Arrhythmias
9.2 Myocardial Ischemia
9.3 Acute Myocardial infraction
10. Cardiac Implant Market Segmentation, by Procedure
10.1 Angioplasty
10.2 Open Heart Surgery
11 Cardiac Implant Market Segmentation, by Material
11.1Metalls and Alloys
11.2 Polymers
11.3 Biological Materials
12 Cardiac implant Market Segmentation, by End User
12.1 Hospitals
12.2 Speciality Clinics
12.3 Others
13. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.1.1 USA Cardiac Implant Market by Device type
11.2.1.2 USA Cardiac Implant Market by Indications
11.2.1.3 USA Cardiac Implant Market by Procedure
11.2.1.4 USA Cardiac Implant Market by Material
11.2.1.5 USA Cardiac Implant Market by End User
11.2.2 Canada
11.2.2.1 Canada Cardiac Implant Market by Device type
11.2.2.2 Canada Cardiac Implant Market by Indications
11.2.2.3 Canada Cardiac Implant Market by Procedure
11.2.2.4 Canada Cardiac Implant Market by Material
11.2.2.5 Canada Cardiac Implant Market by End User
11.2.3 Mexico
11.2.3.1 Mexico Cardiac Implant Market by Device type
11.2.3.2 Mexico Cardiac Implant Market by Indications
11.2.3.3 Mexico Cardiac Implant Market by Procedure
11.2.3.4 Mexico Cardiac Implant Market by Material
11.2.3.5 Mexico Cardiac Implant Market by End User
11.3 Europe
11.3.1 Germany
11.3.1.1 Germany Cardiac Implant Market by Device type
11.3.1.2 Germany Cardiac Implant Market by Indications
11.3.1.2 Germany Cardiac Implant Market by Procedure
11.3.1.4 Germany Cardiac Implant Market by Material
11.3.1.5 Germany Cardiac Implant Market by End User
11.3.2 UK
11.3.2.1 UK Cardiac Implant Market by Device type
11.3.2.2 UK Cardiac Implant Market by Indications
11.3.2.3 UK Cardiac Implant Market by Procedure
11.3.2.4 UK Cardiac Implant Market by Material
11.3.2.5 UK Cardiac Implant Market by End User
11.3.3 France
11.3.3.1 France Cardiac Implant Market by Device type
11.3.3.2 France Cardiac Implant Market by Indications
11.3.3.3 France Cardiac Implant Market by Procedure
11.3.3.4 France Cardiac Implant Market by Material
11.3.3.5 France Cardiac Implant Market by End User
11.3.4 Italy
11.3.4.1 Italy Cardiac Implant Market by Device type
11.3.4.2 Italy Cardiac Implant Market by Indications
11.3.4.3 Italy Cardiac Implant Market by Procedure
11.3.4.4 Italy Cardiac Implant Market by Material
11.3.4.5 Italy Cardiac Implant Market by End User
11.3.5 Spain
11.3.5.1 Spain Cardiac Implant Market by Device type
11.3.5.2 Spain Cardiac Implant Market by Indications
11.3.5.3 Spain Cardiac Implant Market by Procedure
11.3.5.4 Spain Cardiac Implant Market by Material
11.3.5.5 Spain Cardiac Implant Market by End User
11.3.6 The Netherlands
11.3.6.1 Netherlands Cardiac Implant Market by Device type
11.3.6.2 Netherlands Cardiac Implant Market by Indications
11.3.6.3 Netherlands Cardiac Implant Market by Procedure
11.3.6.4 Netherlands Cardiac Implant Market by Material
11.3.6.5 Netherlands Cardiac Implant Market by End User
11.3.7 Rest of Europe
11.3.7.1 Rest of Europe Cardiac Implant Market by Device type
11.3.7.2 Rest of Europe Cardiac Implant Market by Indications
11.3.7.3 Rest of Europe Cardiac Implant Market by Procedure
11.3.7.4 Rest of Europe Cardiac Implant Market by Material
11.3.7.5 Rest of Europe Cardiac Implant Market by End User
11.4 Asia-Pacific
11.4.1 Japan
11.4.1.1 Japan Cardiac Implant Market by Device type
11.4.1.2 Japan Cardiac Implant Market by Indications
11.4.1.3 Japan Cardiac Implant Market by Procedure
11.4.1.4 Japan Cardiac Implant Market by Material
11.4.1.5 Japan Cardiac Implant Market by End User
11.4.2 South Korea
11.4.2.1 South Korea Cardiac Implant Market by Device type
11.4.2.2 South Korea Cardiac Implant Market by Indications
11.4.2.3 South Korea Cardiac Implant Market by Procedure
11.4.2.4 South Korea Cardiac Implant Market by Material
11.4.2.5 South Korea Cardiac Implant Market by End User
11.4.3 China
11.4.3.1 China Cardiac Implant Market by Device type
11.4.3.2 China Cardiac Implant Market by Indications
11.4.3.3 China Cardiac Implant Market by Procedure
11.4.3.4 China Cardiac Implant Market by Material
11.4.3.5 China Cardiac Implant Market by End User
11.4.4 India
11.4.4.1 India Cardiac Implant Market by Device type
11.4.4.2 India Cardiac Implant Market by Indications
11.4.4.3 India Cardiac Implant Market by Procedure
11.4.4.4 India Cardiac Implant Market by Material
11.4.4.5 India Cardiac Implant Market by End User
11.4.5 Australia
11.4.5.1 Australia Cardiac Implant Market by Device type
11.4.5.2 Australia Cardiac Implant Market by Indications
11.4.5.3 Australia Cardiac Implant Market by Procedure
11.4.5.4 Australia Cardiac Implant Market by Material
11.4.5.5 Australia Cardiac Implant Market by End User
11.4.6 Rest of Asia-Pacific
11.4.6.1 APAC Cardiac Implant Market by Device type
11.4.6.2 APAC Cardiac Implant Market by Indications
11.4.6.3 APAC Cardiac Implant Market by Procedure
11.4.6.4 APAC Cardiac Implant Market by Material
11.4.6.5 APAC Cardiac Implant Market by End User
11.5 The Middle East & Africa
11.5.1 Israel
11.5.1.1 Israel Cardiac Implant Market by Device type
11.5.1.2 Israel Cardiac Implant Market by Indications
11.5.1.3 Israel Cardiac Implant Market by Procedure
11.5.1.4Israel Cardiac Implant Market by Material
11.5.1.5Israel Cardiac Implant Market by End User
11.5.2 UAE
11.5.2.1 UAE Cardiac Implant Market by Device type
11.5.2.2 UAE Cardiac Implant Market by Indications
11.5.2.3 UAE Cardiac Implant Market by Procedure
11.5.2.4 UAE Cardiac Implant Market by Material
11.5.2.5 UAE Cardiac Implant Market by End User
11.5.3 South Africa
11.5.3.1 South Africa Cardiac Implant Market by Device type
11.5.3.2 South Africa Cardiac Implant Market by Indications
11.5.3.3 South Africa Cardiac Implant Market by Procedure
11.5.3.4 South Africa Cardiac Implant Market by Material
11.5.3.5 South Africa Cardiac Implant Market by End User
11.5.4 Rest of Middle East & Africa
11.5.4.1 Rest of Middle East & Asia Cardiac Implant Market by Device type
11.5.4.2 Rest of Middle East & Asia Cardiac Implant Market by Indications
11.5.4.3 Rest of Middle East & Asia Cardiac Implant Market by Procedure
11.5.4.4 Rest of Middle East & Asia Cardiac Implant Market by Material
11.5.4.5 Rest of Middle East & Asia Cardiac Implant Market by End User
11.6 Latin America
11.6.1 Brazil
11.6.1.1 Brazil Cardiac Implant Market by Device type
11.6.1.2 Brazil Cardiac Implant Market by Indications
11.6.1.3 Brazil Cardiac Implant Market by Procedure
11.6.1.4 Brazil Cardiac Implant Market by Material
11.6.1.5 Brazil Cardiac Implant Market by End User
11.6.2 Argentina
11.6.2.1 Argentina Cardiac Implant Market by Device type
11.6.2.2 Argentina Cardiac Implant Market by Indications
11.6.2.3 Argentina Cardiac Implant Market by Procedure
11.6.2.4 Argentina Cardiac Implant Market by Material
11.6.2.5 Argentina Cardiac Implant Market by End User
11.6.3 Rest of Latin America
11.6.3.1 Rest of Latin America Cardiac Implant Market by Device type
11.6.3.2 Rest of Latin America Cardiac Implant Market by Indications
11.6.3.3 Rest of Latin America Cardiac Implant Market by Procedure
11.6.3.4 Rest of Latin America Cardiac Implant Market by Material
11.6.3.5 Rest of Latin America Cardiac Implant Market by End User
14 Company Profile
14.1 BIOTRONIC SE& CO.kg,
14.1.1 Market Overview
14.1.2 Financials
14.1.3 Product/Services/Offerings
14.1.4 SWOT Analysis
14.1.5 The SNS View
14.2 Abbott Laboratories,
14.2.1 Market Overview
14.2.2 Financials
14.2.3 Product/Services/Offerings
14.2.4 SWOT Analysis
14.2.5 The SNS View
14.3 AMG International Braun Melungeon Ag,
14.3.1 Market Overview
14.3.2 Financials
14.3.3 Product/Services/Offerings
14.3.4 SWOT Analysis
14.3.5 The SNS View
14.4 Johnson & Johnson Services, Inc,
14.4.1 Market Overview
14.4.2 Financials
14.4.3 Product/Services/Offerings
14.4.4 SWOT Analysis
14.4.5 The SNS View
14.5 W L Gore & Associates,
14.5.1 Market Overview
14.5.2 Financials
14.5.3 Product/Services/Offerings
14.5.4 SWOT Analysis
14.5.5 The SNS View
14.6 Inc Medtronic Private limited,
14.6.1 Market Overview
14.6.2 Financials
14.6.3 Product/Services/Offerings
14.6.4 SWOT Analysis
14.6.5 The SNS View
14.7 Boston Scientific Corporation,
14.7.1 Market Overview
14.7.2 Financials
14.7.3 Product/Services/Offerings
14.7.4 SWOT Analysis
14.7.5 The SNS View
14.8 Sorin Corporation
14.8.1 Market Overview
14.8.2 Financials
14.8.3 Product/Services/Offerings
14.8.4 SWOT Analysis
14.8.5 The SNS View
14.9 Edward Life science Corporation,
14.9.1 Market Overview
14.9.2 Financials
14.9.3 Product/Services/Offerings
14.9.4 SWOT Analysis
14.9.5 The SNS View
14.10 Cryolife Inc.
14.10.1 Market Overview
14.10.2 Financials
14.10.3 Product/Services/Offerings
14.10.4 SWOT Analysis
14.10.5 The SNS View
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share Analysis
15.3 Recent Developments
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
